| Title | Chemotherapy |
| Abbreviation | Chemotherapy |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Oncology (Q3) |
| h-index | 59 |
| Overall Rank/Ranking | 8141 |
| SCImago Journal Rank (SJR) | 0.627 |
| Impact Score | 3.32 |
| Publisher | S. Karger AG |
| Country | Switzerland |
| ISSN | 00093157, 14219794 |
| Best Quartile | Q2 |
| Coverage History | 1960-2022 |
This journal publishes original research articles and state-of-the-art reviews on all aspects of antiinfective and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.
Chemotherapy is a journal covering the technologies/fields/categories related to Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Oncology (Q3). It is published by S. Karger AG. The overall rank of Chemotherapy is 8141. According to SCImago Journal Rank (SJR), this journal is ranked 0.627. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 59. The best quartile for this journal is Q2.
The ISSN of Chemotherapy journal is 00093157, 14219794. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Chemotherapy is cited by a total of 305 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Chemotherapy is 3.32, which is computed in 2023 as per its definition. Chemotherapy IF is increased by a factor of 0.39 and approximate percentage change is 13.31% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Chemotherapy is 3.32. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.32 |
| 2021 | 2.93 |
| 2020 | 2.30 |
| 2019 | 1.65 |
| 2018 | 1.48 |
| 2017 | 1.74 |
| 2016 | 1.74 |
| 2015 | 1.52 |
| 2014 | 2.41 |
Chemotherapy has an h-index of 59. It means 59 articles of this journal have more than 59 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Chemotherapy is 00093157, 14219794. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Chemotherapy is 8141. According to SCImago Journal Rank (SJR), this journal is ranked 0.627. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.627 |
| 2021 | 0.742 |
| 2020 | 0.539 |
| 2019 | 0.488 |
| 2018 | 0.472 |
| 2017 | 0.524 |
| 2016 | 0.536 |
| 2015 | 0.635 |
| 2014 | 0.724 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 8141 |
| 2021 | 6336 |
| 2020 | 9372 |
| 2019 | 9998 |
| 2018 | 9968 |
| 2017 | 8884 |
| 2016 | 8742 |
| 2015 | 7455 |
| 2014 | 6425 |
Chemotherapy is published by S. Karger AG. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 1960-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Chemotherapy is Chemotherapy. This abbreviation ('Chemotherapy') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Oncology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Chemotherapy latest impact IF is 3.32. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.32 (2022) and 1.48 (2018), respectively, in the last 9 years. Moreover, its average IS is 2.12 in the previous 9 years.
The Chemotherapy has an SJR (SCImago Journal Rank) of 0.627, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.742 in 2021 and the lowest being 0.472 in 2018. Furthermore, the average SJR of the Chemotherapy over the previous 9-year period stands at 2.12.
The latest h-index of the Chemotherapy is 59.
The Chemotherapy is published by the S. Karger AG, with its country of publication being the Switzerland.
The Chemotherapy is currently ranked 8141 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 6336 in 2021 and its lowest position of 9998 in 2019.
The standard ISO4 abbreviation for the Chemotherapy is Chemotherapy.
Chemotherapy is classified as a journal that the S. Karger AG publishes.
The Chemotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Chemotherapy is assigned the following International Standard Serial Numbers (ISSN): 00093157, 14219794.
The best quartile for the Chemotherapy is Q2 (2022).
The Chemotherapy coverage history can be summarized as follows: 1960-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Applied Ecology and Environmental Research | journal | 17545 | Corvinus University of Budapest | 38 | 0.74 |
| Current Sociology | journal | 6591 | SAGE Publications Ltd | 76 | 2.29 |
| Journal of Competition Law and Economics | journal | 14815 | Oxford University Press | 29 | 0.72 |
| CESifo Economic Studies | journal | 14012 | Oxford University Press | 32 | 1.70 |
| Materials Research | journal | 14791 | Universidade Federal de Sao Carlos | 65 | 1.62 |
| Canadian Journal of Education | journal | 17961 | Canadian Society for the Study of Education (CSSE) | 41 | 0.39 |
| British Journal of Special Education | journal | 12024 | Wiley-Blackwell Publishing Ltd | 42 | 1.24 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 25369 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Journal of Imaging Science and Technology | journal | 19249 | Society for Imaging Science and Technology | 44 | 0.96 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.32 |
| 2021 | 2.93 |
| 2020 | 2.30 |
| 2019 | 1.65 |
| 2018 | 1.48 |
| 2017 | 1.74 |
| 2016 | 1.74 |
| 2015 | 1.52 |
| 2014 | 2.41 |
